How RiteFlo™ Is Different From Other Devices That Use a Whistle?
- RiteFlo™ has a built in baffle design with a fixed flow regulator, therefore no whistle system is required to alert the patient of incorrect high speed inhalation.
- RiteFlo™ is a spacer/holding chamber that “Assures the 2007 NHLBI/EPRIII Guidelines for 30 L/min flow rate” with every breath.
- With the right controlled inhalational flow rate, (now you know how we came up with our Brand Name) patients have a better chance of getting more medicine into their lungs.
- None of the currently FDA cleared spacers/holding chambers control flow rate at all. Holding chambers use whistle alarms to alert the user that their flow rate is too fast. Unfortunately, children like to hear the whistle and get the wrong flow rate.
- The Whistle System is over 20 years old and is an attempt to educate patients on slow flow rate. Some spacers/holding chambers on the market cannot activate a whistle reliably as the NHLBI (National Heart, Lung,Blood Institute) has recommended at the flow rate of 30 L/ min.
- RiteFlo™ is an effective holding chamber that does not require valves. No cleaning or replacement of valves required.
- RiteFlo™ enhances correct inhalation technique. No device needed to educate patients on how to inspire at 30L/min.
- Correct inspiratory flow rate (30L/min) is critical to improving deep penetration of drug into the lung. Deeper lung penetration of medication targets the site of disease activity in asthma.
Why You Should Inhale Your MDI (Metered Dose Inhaler) Inhaler Slowly?
- Did you know that the faster you inhale your medicine the less it gets into your lungs?
- Most, if not all, patients try to inhale as fast as they can to try to get as much medicine into their lungs, yet this is exactly the wrong way to use your inhaler.
- Very slow constant inhalation allows for smaller particles to float down deeper into your lungs and not settle in your mouth.
- Clinical studies have shown that rapid inhalation of medication results in anywhere from 30-60 percent of the medicine staying in the mouth.
- Decreased oral deposition results in fewer side effects from inhaled steroids.